HomeCompareAELTF vs MRK

AELTF vs MRK: Dividend Comparison 2026

AELTF yields 2000000.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AELTF wins by $1.6247481716182984e+23M in total portfolio value
10 years
AELTF
AELTF
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.6247481716182984e+23M
Annual income
$147,608,011,402,949,780,000,000,000,000.00
Full AELTF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — AELTF vs MRK

📍 AELTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAELTFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AELTF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AELTF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AELTF
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$125,466,809,692,507,310,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, AELTF beats the other by $125,466,809,692,507,310,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AELTF + MRK for your $10,000?

AELTF: 50%MRK: 50%
100% MRK50/50100% AELTF
Portfolio after 10yr
$8.123740858091492e+22M
Annual income
$73,804,005,701,474,890,000,000,000,000.00/yr
Blended yield
90.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

AELTF
No analyst data
Altman Z
0.9
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AELTF buys
0
MRK buys
0
No recent congressional trades found for AELTF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAELTFMRK
Forward yield2000000.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$1.6247481716182984e+23M$56.8K
Annual income after 10y$147,608,011,402,949,780,000,000,000,000.00$9,798.13
Total dividends collected$1.6146053563276882e+23M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AELTF vs MRK ($10,000, DRIP)

YearAELTF PortfolioAELTF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$100,010,700$100,000,000.00$11,206$366.19+$100.00MAELTF
2$467,446,731,075$467,339,719,626.17$12,650$502.35+$467446.72MAELTF
3$1,021,215,363,816,662$1,020,715,195,814,411.90$14,407$694.19+$1021215363.80MAELTF
4$1,043,112,617,104,109,200$1,042,019,916,664,825,300.00$16,585$967.82+$1043112617104.09MAELTF
5$498,482,143,759,731,400,000$497,366,013,259,430,040,000.00$19,342$1,363.89+$498482143759731.38MAELTF
6$111,599,275,650,097,780,000,000$111,065,899,756,274,860,000,000.00$22,913$1,947.19+$111599275650097776.00MAELTF
7$11,738,678,336,351,557,000,000,000$11,619,267,111,405,953,000,000,000.00$27,662$2,823.89+$11738678336351557632.00MAELTF
8$583,674,362,697,175,100,000,000,000$571,113,976,877,278,900,000,000,000.00$34,159$4,173.35+$583674362697175072768.00MAELTF
9$13,894,210,989,607,547,000,000,000,000$13,269,679,421,521,570,000,000,000,000.00$43,337$6,308.80+$1.3894210989607547e+22MAELTF
10$162,474,817,161,829,840,000,000,000,000$147,608,011,402,949,780,000,000,000,000.00$56,776$9,798.13+$1.6247481716182984e+23MAELTF

AELTF vs MRK: Complete Analysis 2026

AELTFStock

Adacel Technologies Limited develops and sells air traffic management, air traffic control simulation, and training systems and services for the military and civil sectors primarily in the United States, Canada, Estonia, and Australia. It operates through Systems and Services segments. The Systems segment is involved in the sale of advanced systems, technical software, and hardware. The Services segment includes development and support, and field technical services. The company also offers Aurora air traffic management (ATC) solution for providing oceanic, procedural, and mixed surveillance airspace control; MaxSim air traffic simulator training system; AeroDrive, an immersive training simulator to train airport drivers in a 3-D environment; and intelligent communications environment, an aviation phraseology training tool for air traffic controllers and pilots. In addition, it provides REVAL virtual ATC tower system that delivers digital tower operational solutions. The company was founded in 1987 and is headquartered in Port Melbourne, Australia.

Full AELTF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this AELTF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AELTF vs SCHDAELTF vs JEPIAELTF vs OAELTF vs KOAELTF vs MAINAELTF vs JNJAELTF vs ABBVAELTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.